Alaunos Therapeutics Inc (TCRT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Alaunos Therapeutics Inc   (NASDAQ: TCRT)

Alaunos Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




TCRT Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 67.76 % 64.81 % 46.17 %
Gross Margin (Q2 TTM) - 69.77 % 63.91 % 45.96 %
Gross Profit Margin 5 Yr. Avg. 60 % 68.59 % 65.27 % 47.54 %
EBITDA Margin (Q2 MRQ) - 24.1 % 21.69 % 20.81 %
EBITDA Margin (Q2 TTM) - 25.3 % 20.74 % 19.32 %
EBITDA Margin 5 Yr. Avg. 1275.35 % 34.48 % 25.83 % 21.84 %
Operating Margin (Q2 MRQ) - 19.68 % 18.32 % 15.88 %
Operating Margin (Q2 TTM) - 18.91 % 16.39 % 15.55 %
Operating Margin 5 Yr. Avg. --167729.22 % 13.96 % 13.31 % 16.97 %
Pre-Tax Profit Margin (Q2 MRQ) - 17.28 % 14.29 % 13.29 %
Pre-Tax Profit Margin (Q2 TTM) - 16.78 % 12.44 % 12.41 %
Pre-Tax Profit Margin 5 Yr. Avg. - 11.99 % 9.87 % 11.9 %
Net Margin (Q2 MRQ) - 13.16 % 10.78 % 10.26 %
Net Margin (Q2 TTM) - 15.04 % 10.56 % 10.03 %
Net Margin 5 Yr. Avg. - 7.73 % 7.17 % 9.59 %